[2026 Edition] Healthcare Industry M&A News Roundup – M&A Best Partners Co., Ltd.

This news presents a compilation of M&A news in the medical and healthcare industry for 2026, compiled by M&A Best Partners Co., Ltd., and explains its significance and specific points for consideration.

This compilation is not merely a collection of past cases but suggests the increasing activity of M&A as a response to business succession and successor issues faced by medical institutions. In particular, it highlights the current trend where "third-party succession M&A" is increasingly emphasized as a strategy that enhances the possibility of achieving a win-win-win outcome by securing transfer value, maintaining staff employment, and ensuring continuous medical care for patients, rather than choosing closure or廃業 (business closure).

For medical institution executives and those facing successor issues, this news strongly urges the necessity of "early consideration." Starting preparations for business succession and M&A with a long-term perspective of 5-10 years, from around the age of 60 for the chairman or director, is key to achieving a smooth succession. Furthermore, utilizing specialized advisors focused on the medical industry (e.g., Small and Medium Enterprise Agency-certified M&A support institutions like M&A Medical) is essential for navigating complex procedures and regulations and establishing an optimal succession scheme.

Utilizing free consultations and preliminary valuations during the initial consideration phase, such as "wanting to know the market value" or "wanting to compare options before closing," serves as the first step towards concrete action. This news indicates that medical institutions are in a phase where they should actively consider M&A to establish sustainable management strategies for the future.